BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 38578203)

  • 1. Assessing immune hepatotoxicity of troglitazone with a versatile liver-immune-microphysiological-system.
    Deng Q; Yang Y; Liu Y; Zou M; Huang G; Yang S; Li L; Qu Y; Luo Y; Zhang X
    Front Pharmacol; 2024; 15():1335836. PubMed ID: 38873410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immuno-inflammatory
    Roser LA; Luckhardt S; Ziegler N; Thomas D; Wagner PV; Damm G; Scheffschick A; Hewitt P; Parnham MJ; Schiffmann S
    Front Immunol; 2023; 14():1275368. PubMed ID: 38045689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-2-mediated hepatotoxicity: knowledge gap identification based on the irAOP concept.
    Roser LA; Sakellariou C; Lindstedt M; Neuhaus V; Dehmel S; Sommer C; Raasch M; Flandre T; Roesener S; Hewitt P; Parnham MJ; Sewald K; Schiffmann S
    J Immunotoxicol; 2024 Dec; 21(1):2332177. PubMed ID: 38578203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiosyncratic drug hepatotoxicity.
    Kaplowitz N
    Nat Rev Drug Discov; 2005 Jun; 4(6):489-99. PubMed ID: 15931258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Important role of proinflammatory cytokines/other endogenous substances in drug-induced hepatotoxicity: depression of drug metabolism during infections/inflammation states, and genetic polymorphisms of drug-metabolizing enzymes/cytokines may markedly contribute to this pathology.
    Prandota J
    Am J Ther; 2005; 12(3):254-61. PubMed ID: 15891270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety data and withdrawal of hepatotoxic drugs.
    Babai S; Auclert L; Le-Louët H
    Therapie; 2021; 76(6):715-723. PubMed ID: 29609830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatotoxicity and hepatic metabolism of available drugs: current problems and possible solutions in preclinical stages.
    Giri S; Nieber K; Bader A
    Expert Opin Drug Metab Toxicol; 2010 Aug; 6(8):895-917. PubMed ID: 20367107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hepatotoxicity assessment of micro/nanoplastics: A preliminary study to apply the adverse outcome pathways.
    Ge Y; Yang S; Zhang T; Wan X; Zhu Y; Yang F; Yin L; Pu Y; Liang G
    Sci Total Environ; 2023 Dec; 902():165659. PubMed ID: 37517720
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.